Medical AI Alliance
← Company Index
Pharma & CDMOKOSDAQ 23469046 approvals4 trials

GC WellBeing Corporation

Official website

KOSDAQ-listed company selling the placental hydrolysate injection Rainec Inj. and the HA filler Youthfill across pharmaceuticals and aesthetics.

As of 2026-10-08, GC WellBeing Corporation has 1 Korean MFDS device approval, 45 Korean MFDS drug approvals, 2 PubMed-indexed papers on record (counted by the MAA Company Index from its own matching of public databases).

Price

Change

Market cap

Business overview

Source: DART corporate disclosure

Founded in 2004 and listed on KOSDAQ in 2019, GC WellBeing is a company spanning prescription pharmaceuticals, health functional foods, and aesthetic medical devices. Its flagship product, Rainec Inj., Korea's only placental hydrolysate injection, is sold alongside 48 types of nutritional injections and medical devices such as the HA filler Youthfill, skin booster Pilode, and collagen booster Duragen, and the company has also begun domestic sales of the Swedish-strain botulinum toxin Inibo. 2025 standalone revenue was KRW 151.9 billion, up 18.8% from KRW 127.9 billion the prior year, and its physician-channel health functional food brand Dr.PNT offers around 32 products.

Products & technology

  • Rainec Inj.Placental hydrolysate injection for liver function improvement
  • Youthfill (HA filler)Class 4 medical device for facial volume and wrinkle correction
  • IniboBotulinum toxin from a Swedish clean strain
  • Dr.PNTPhysician-channel health functional food brand (vitamins, probiotics, etc.)

Regulatory approvals

data.go.kr

45 Korean MFDS drug approvals · 1992–2025 / 1 Korean MFDS device approvals · 2025

  • MFDS drugHealroad once Inj.2025-05-21
    Drug · Prescription · Approval202501248
  • MFDSTraction unit, air-powered, manually-operatedRevoked2025-03-25
    Product approval · Class 1제신 25-363 호
  • MFDS drugHealroad Plus Inj.2024-08-13
    Drug · Prescription · Approval202401971
  • MFDS drugHealroad Inj.2023-10-30
    Drug · Prescription · Approval202303026
  • MFDS drugGCWBVITATWO inj. (Riboflavin sodium phosphate)Revoked2022-06-15
    Drug · Prescription · Notification202202502
  • MFDS drugGCWBVITANINE inj. (Folic Acid)2022-04-14
    Drug · Prescription · Notification202201561
  • MFDS drugGCWB Magnesium Chloride inj.2021-02-19
    Drug · Prescription · Notification202101707
  • MFDS drugGCWB Selenium Oral Dissolving Film2020-12-31
    Drug · OTC · Approval202009404
  • MFDS drugGCWB BONHEALTH inj.2020-11-23
    Drug · Prescription · Notification202008109
  • MFDS drugGC WellBeing Deoxy Inj.2020-11-09
    Drug · Prescription · Notification202007667
  • MFDS drugGC Wellbeing Immun Alpha 1 Inj.2020-08-18
    Drug · Prescription · Approval202005847
  • MFDS drugGC Wellbeing Acetaminophen Inj.2020-02-13
    Drug · Prescription · Notification202000931
Show 34 more
  • MFDS drugGC WellBeing Neuramin Inj.Revoked2019-11-13
    Drug · Prescription · Notification201907901
  • MFDS drugGC WellBeing Amino Inj.Revoked2019-11-13
    Drug · Prescription · Notification201907902
  • MFDS drugPNT-sami Inj2019-07-30
    Drug · Prescription · Notification201905399
  • MFDS drugGC vita12 Inj.2017-12-13
    Drug · Prescription · Notification201708334
  • MFDS drugGCWB Glymeta Inj.2017-07-28
    Drug · Prescription · Notification201706238
  • MFDS drugGC Ginkgo Injection2017-05-23
    Drug · Prescription · Notification201702532
  • MFDS drugGC ARGININE inj.2016-12-19
    Drug · Prescription · Notification201607169
  • MFDS drugGC SELENIUM inj.2016-10-28
    Drug · Prescription · Notification201606336
  • MFDS drugGC Multi 5 Inj.2016-10-10
    Drug · Prescription · Notification201605985
  • MFDS drugGC Multi 12 Inj.2016-09-01
    Drug · Prescription · Notification201605356
  • MFDS drugGCB Bone Injection2016-02-11
    Drug · Prescription · Notification201600795
  • MFDS drugGC CALCIUM GLUCONATE inj.2015-10-20
    Drug · Prescription · Notification201507258
  • MFDS drugGC Tatihione Inj. 1200mg2015-08-31
    Drug · Prescription · Notification201506222
  • MFDS drugGC VITAD inj.2015-06-30
    Drug · Prescription · Notification201504236
  • MFDS drugEsozole Cap. 20mg(Esomeprazole pellets)2015-05-21
    Drug · Prescription · Approval201503039
  • MFDS drugEsozole Cap. 40mg(Esomeprazole pellets)2015-05-21
    Drug · Prescription · Approval201503040
  • MFDS drugGCNAC Inj.2015-02-24
    Drug · Prescription · Notification201500956
  • MFDS drugGC Zinc Injection2015-01-20
    Drug · Prescription · Notification201500301
  • MFDS drugGCTrace InjectionRevoked2015-01-19
    Drug · Prescription · Notification201500267
  • MFDS drugGCtathione Injection 600mg2014-12-31
    Drug · Prescription · Notification201406164
  • MFDS drugGC Vita O Injection2014-11-28
    Drug · Prescription · Notification201405626
  • MFDS drugThioctic Acid Inj. GC2014-11-25
    Drug · Prescription · Notification201405517
  • MFDS drugGC Cartine Inj.2014-10-27
    Drug · Prescription · Notification201404971
  • MFDS drugLaennecP.O. Cap.Revoked2014-08-01
    Drug · OTC · Approval201403583
  • MFDS drugLaennec P.O. CAPSULERevoked2014-03-13
    Drug · OTC · Approval201401144
  • MFDS drugMeganessium Injection 10%2013-12-12
    Drug · Prescription · Notification201310661
  • MFDS drugMegavitasix Injection2013-12-11
    Drug · Prescription · Notification201310621
  • MFDS drugJ-Pla Injection2011-11-28
    Drug · Prescription · Approval201110423
  • MFDS drugLainec Inj. Vial2011-02-23
    Drug · Prescription · Approval201100874
  • MFDS drugHishiphagen-C Inj.Revoked2008-05-09
    Drug · Prescription · Notification200805354
  • MFDS drugMegagreen2007-11-14
    Drug · Prescription · Notification200712460
  • MFDS drugFursultamine Inj.2007-04-18
    Drug · Prescription · Notification200704485
  • MFDS drugLaennec Inj.2005-04-13
    Drug · Prescription · Approval200512342
  • MFDS drugPotemin Inj1992-06-09
    Drug · Prescription · Notification199200566

Clinical trials

data.go.kr

4 MFDS clinical trial authorisations · 2017–2024 (Phase 3 2 · Phase 2a 2)

  • Phase 3라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2024-04-25

    37 trial sites

  • Phase 2a라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2021-02-26

    3 trial sites

  • Phase 2a라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2020-08-11

    8 trial sites

  • Phase 3라이넥주(자하거가수분해물)(수출명: LAENNEC INJ.)2017-11-14

    3 trial sites

Publications

PubMed · affiliation-matched

Patents

KIPRIS · applicant-matched
Show 41 more patents

AI reads

MAA server logs · IP-verified
75
Times AI engines pulled GC WellBeing Corporation's records

Pulled records become part of each AI's index and keep feeding its answers. When an AI cites from that index, nothing reaches our server — so actual citations are uncounted here and exceed this number.

3
Fetched fresh mid-answer

Times an AI needed something not yet in its index and fetched this page fresh while answering. Citations served from the index leave no trace here.

72
Index crawls

Collected as raw material for future answers.

0
Direct AI-tool queries (MCP)

Queries from users who connected this index to their own AI.

11
live 0
Last 7 days
57
live 3
Last 30 days
75
live 3
All time
  • OpenAIChatGPT-Userlive3
  • OpenAIOAI-SearchBot66
  • PerplexityPerplexityBot2
  • AnthropicClaudeBot2
  • MicrosoftBingbot1
  • GoogleGoogleOther1

Measured since Aug 25, 2026 · 5 AI engines · last read Oct 8, 2026

User-agent strings can be forged, so we do not count them at face value. We count only requests matched against vendor-published IP ranges, or confirmed by forward-verified reverse DNS. MCP queries are actual calls to this index's tool endpoint.

Connect this index to your AI tool →

Connect this company index directly to your AI

Connect it to ChatGPT or Claude, and your AI queries the full record — profiles, financials, stock data, regulatory approvals, clinical trials, publications and patents — for GC WellBeing Corporation and every listed Korean medical, bio and AI company.

How to connect (MCP)
Not yet compiled: business overview · R&D. Send us materials and we will add them

Companies in the same categoryPharma & CDMO

ILDONG HOLDINGS CO.,LTD100

Founded in 1941 and listed on the KOSPI in 1975, Ildong Holdings is the holding company of the Ildong Pharmaceutical Group, overseeing pharmaceutical, aesthetic medical device, and drug development affiliates.

Yuyu Pharma, Inc.100

Founded in 1941 and listed on the KOSPI in 1975, Yuyu Pharma is a pharmaceutical company with a co-promotion agreement with Dong-A ST for Tanamin.

IL DONG PHARMACEUTICAL CO., LTD.100

Founded and listed on the KOSPI in 2016, Il Dong Pharmaceutical manufactures products including the Aronamin vitamin line.

Medy-Tox Inc.99

Founded 2000, KOSDAQ-listed 2009, Medy-Tox develops and exports botulinum toxin biopharmaceuticals including Meditoxin and Innotox.

GC Biopharma Corp.97

KOSPI-listed comprehensive pharmaceutical company specializing in blood products and vaccines, with FDA-approved immunoglobulin ALYGLO.

DAEWON PHARMACEUTICAL CO.,LTD85

KOSPI-listed pharmaceutical company behind Coldwon cold medicine and Jangdaewon probiotics, developing a P-CAB drug pipeline.

SAMSUNG BIOLOGICS CO.,LTD.85

Founded 2011, listed 2016 — Samsung Biologics is a biopharma CDMO with 785,000L capacity across five Songdo plants.

GENOLUTION INC.85

Founded in 2006 and listed on KOSDAQ in 2020, Genolution is a molecular diagnostics and RNAi company producing nucleic acid extraction reagents and devices.

AHN-GOOK PHARMACEUTICAL Co., Ltd.85

Ahn-Gook Pharmaceutical sells the cough/expectorant drug Sinecuran and the eye-health supplement Tobicom.

CORESTEMCHEMON Inc.85

Founded in 2003 and listed on KOSDAQ in 2015, Corestem Chemon develops stem cell therapies and provides nonclinical CRO services, including the ALS treatment Neuronata-R.

BIO-FD&C CO.,LTD.85

Founded 2005, KOSDAQ-listed 2022, BIO-FD&C develops plant-cell platform-based cosmeceutical materials and biopharma pipelines.

HANDOK Inc.85

KOSPI-listed comprehensive pharma company behind Amaryl diabetes drug and the USD 86.25M HL5101 anticancer out-license deal.

Sources and updates

Counts on this page are not company-reported figures. MAA matched records from DART, the Korean MFDS, the US FDA, ClinicalTrials.gov, PubMed and KIPRIS to this company itself, by business registration number or registered name, never by name similarity. They may differ from figures the company publishes.

Company basics
Korea Exchange · DART
Business content
Compiled from disclosure filings
Approvals & clinical trials
Korean MFDS (data.go.kr) · US FDA openFDA — updated weekly
Key disclosures
KRX KIND via OpenDART exchange filings — updated daily
Global clinical trials
ClinicalTrials.gov (US NIH) — sponsor-matched, updated weekly
Financials
DART corporate disclosure filings — annual
Publications
PubMed (US National Library of Medicine) — affiliation-matched, updated daily
Patents
KIPRIS (Korea Institute of Patent Information) — applicant-matched, updated monthly
AI reads
Our server logs, IP-verified every 6 hours
AI visibility
Measured 2026-10-01

This page is compiled from public sources without the company's involvement. If anything is inaccurate or incomplete, please let us know. Materials provided by the company are labelled as such.

Request a correction or addition